ticlopidine has been researched along with nitrites in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gryglewski, RJ; Marcinkiewicz, E; Olszanecki, R; Uracz, W; Ziemianin, B | 1 |
Akimoto, T; Amemiya, M; Asano, Y; Iimura, O; Inoue, M; Ito, C; Kusano, E; Muto, S; Nemoto, J | 1 |
Arrebola, M; De La Cruz, P; de la Cuesta, FS; González-Correa, A; Martinez-Cerdán, E; Moreno, A | 1 |
Anderson, RA; Bundhoo, S; James, PE; Sagan, E | 1 |
4 other study(ies) available for ticlopidine and nitrites
Article | Year |
---|---|
Thienopyridines: effects on cultured endothelial cells.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta; Aspirin; Calcimycin; Calcium; Cattle; Cell Line; Cell Survival; Cells, Cultured; Clopidogrel; Dose-Response Relationship, Drug; Drug Interactions; Endothelium, Vascular; Epoprostenol; Humans; Nitrites; Platelet Aggregation Inhibitors; Pyridines; Ticlopidine; Time Factors; Umbilical Veins | 1999 |
The anti-platelet agent, ticlopidine, upregulates interleukin-1-Beta-stimulated nitric oxide production in cultured rat vascular smooth muscle cells.
Topics: Animals; Aorta; Cells, Cultured; Cyclic AMP; Cyclic GMP; Interleukin-1; Male; Muscle, Smooth, Vascular; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Ticlopidine; Up-Regulation | 2002 |
Effects of clopidogrel and ticlopidine on experimental diabetic ischemic retinopathy in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Administration, Oral; Animals; Clopidogrel; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Dose-Response Relationship, Drug; Male; Nitrates; Nitric Oxide; Nitrites; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Retinal Vessels; Thromboxane B2; Ticlopidine | 2003 |
Clopidogrel results in favourable changes in nitric oxide metabolism in patients undergoing percutaneous coronary intervention.
Topics: Biomarkers; Clopidogrel; Coronary Artery Disease; Cyclic GMP; Humans; Nitrates; Nitric Oxide; Nitrites; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Stents; Ticlopidine; Time Factors; Treatment Outcome; Vasodilation; Wales | 2014 |